Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200122046221N1
IRCT20200122046221N1
Recruiting
Phase 3

Comparison of the efficacy and side effects of oxytocin + misoprostol with methyl ergonovine (metergin) + misoprostol and misoprostol alone in the excretion of pregnancy products.

Jahrom University of Medical Sciences0 sites90 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Jahrom University of Medical Sciences
Enrollment
90
Status
Recruiting
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Jahrom University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •tendency toward outpatient treatment
  • •gestational age less than 14 week
  • •not presence of high risk disease

Exclusion Criteria

  • •presence of a major disease
  • •the patients who can not tolerate drugs
  • •those who get tired from the process of treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Comparing the efficacy of morphine sulfate and oxycodone in pain managementAcute lower limb injury.Superficial injury of hip and thigh, Fracture of femur, Dislocation, sprain and strain of joint and ligaments of hip, Injury of muscle and tendon at hip and thigh level, Crushing injury of hip and thigh, Traumatic amputation of hip and thigh, Superficials70, s72,
IRCT201204089387N2Vice Chancellor for Research, Tehran University of Medical Sciences40
Not yet recruiting
Not Applicable
se of ozone gas in treating muscle pai
CTRI/2023/12/060721ational Institute of Naturopathy
Recruiting
Phase 3
Evaluation of local effect of Oxybutynin in treatment of palmar hyperhidrosis
IRCT20210822052255N1Shiraz University of Medical Sciences30
Active, not recruiting
Phase 3
Comparison of the efficacy of oxtyocin agonist to oxytocin in the prevention of postpartum hemorrhage (PPH) in women undergoing vaginal deliveryPostpartum Hemorrhagevaginal deliveryvaginal delivery and blood lossReproductive Health and Childbirth - Childbirth and postnatal care
ACTRN12608000396325Dr Farouk720
Completed
Not Applicable
Effect of Ondansetron and Granisetron For The Prevention Of Pruritus In Patients Undergoing Cesarean SectioPruritus.Pruritus, unspecified
IRCT2014092219252N1Ahwaz Jondishapour University of Medical Sciences90